Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis

被引:0
作者
Toshihiro Nagai
Masato Sato
Miyuki Kobayashi
Munetaka Yokoyama
Yoshiki Tani
Joji Mochida
机构
[1] Tokai University School of Medicine,Department of Orthopaedic Surgery, Surgical Science
来源
Arthritis Research & Therapy | / 16卷
关键词
Vascular Endothelial Growth Factor; Bevacizumab; Articular Cartilage; Subchondral Bone; Vascular Endothelial Growth Factor Expression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 231 条
[1]  
Steadman JR(1999)The microfracture technic in the management of complete cartilage defects in the knee joint. [Article in German] Orthopade 28 26-32
[2]  
Rodkey WG(2005)Mosaicplasty: long-term follow-up Bull Hosp Jt Dis 63 54-62
[3]  
Briggs KK(1994)Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation N Engl J Med 331 889-895
[4]  
Rodrigo JJ(2010)Long-term durability of autologous chondrocyte implantation: a multicenter, observational study in US patients Am J Sports Med 38 238-246
[5]  
Szerb I(1994)Operative treatment of osteoarthrosis. Current practice and future development J Bone Joint Surg Am 76 1405-1418
[6]  
Hangody L(1994)Joint resurfacing using allograft chondrocytes and synthetic biodegradable polymer scaffolds J Biomed Mater Res 28 891-899
[7]  
Duska Z(2005)Articular cartilage engineering with Hyalograft C: 3-year clinical results Clin Orthop Relat Res 435 96-105
[8]  
Kaposi NP(2001)Articular cartilage repair using a tissue-engineered cartilage-like implant: an animal study Osteoarthr Cartil 9 S6-S15
[9]  
Brittberg M(2008)Characteristics of a scaffold-free articular chondrocyte plate grown in rotational culture Tissue Eng Part A 14 1183-1193
[10]  
Lindahl A(2008)Optimization of allograft implantation using scaffold-free chondrocyte plates Tissue Eng Part A 14 1225-1235